Fortis Healthcare Launches Lung Failure Clinics in New Delhi to Enhance Advanced Respiratory and Transplant Care

Date:

Share post:

Fortis Healthcare has announced the launch of dedicated Lung Failure Clinics at its Shalimar Bagh and Vasant Kunj facilities in New Delhi. The initiative establishes a specialized, multidisciplinary care model to provide end-to-end evaluation, targeted therapies, and transplant pathways for patients living with progressive and end-stage respiratory diseases.

​The clinics are designed to manage complex conditions such as Interstitial Lung Disease (ILD), severe Chronic Obstructive Pulmonary Disease (COPD), pulmonary fibrosis, and pulmonary hypertension. Led by experienced teams in pulmonology, respiratory critical care, and lung transplant surgery, the centersintegrate advanced diagnostics, interventional bronchoscopy, structured pulmonary rehabilitation, non-invasive ventilation, and nutritional counselling under one roof.

​For individuals with irreversible disease progression, the clinics offer early eligibility screening, pre-transplant counselling, and post-transplant follow-up protocols. The critical need for early clinical intervention was underscored by a recent clinical milestone at Fortis Hospital, Shalimar Bagh, where a 29-year-old physiotherapist with deteriorating end-stage ILD received a life-saving double-lung transplant following timely multidisciplinary referral.

​Medical specialists noted that environmental pollution, tobacco use, occupational risks, and chronic infections are contributing to a growing burden of respiratory illnesses across the National Capital Region. Many patients seek tertiary intervention only after advanced functional impairment has set in. By operating structured outpatient services including specialized sessions every Tuesday and Friday at Fortis Shalimar Bagh the new clinics aim to bridge this critical gap, facilitating earlier referral, slowing disease progression, and improving survival outcomes for patients with severe lung failure.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

AIIA Rolls Out “Garbhini Mitra” Programme to Widen Community-Level Maternal Support Through Ayurveda

The All India Institute of Ayurveda (AIIA) in New Delhi, an autonomous body under the Ministry of Ayush, has...

GSK’s Hibsago Becomes World’s First Approved Functional Cure for Chronic Hepatitis B

GSK has secured its first global regulatory approval for Hibsago(bepirovirsen), marking the debut of a functional cure option for...

Symbiotec Pharmalab Announces ₹1,757 Crore IPO to Fuel Biopharma Growth

Symbiotec Pharmalab, a leading research and development-driven pharmaceutical and biotechnology player, has announced details of its ₹1,757 crore Initial...

Pharmacy Council of India Introduces M.Pharm Specialisation in Medical Devices

The Pharmacy Council of India (PCI) has officially notified an amendment to the Master of Pharmacy (M.Pharm) Course...